Sher AA et al. |
[Interactions in the system of copper ion-azalide (azithromycin)]. |
1994 Sep-Oct |
Antibiot. Khimioter. |
pmid:7695446
|
Iakovlev SV and Ukhin SA |
[Azithromycin: general properties and regimen optimization based on pharmacokinetic and pharmacological parameters]. |
2003 |
Antibiot. Khimioter. |
pmid:12803047
|
Kuznetsova SM |
["Sumamed in the treatment of urogenital infections"]. |
1996 |
Antibiot. Khimioter. |
pmid:8929115
|
Skripkin IuK et al. |
[The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. |
1996 |
Antibiot. Khimioter. |
pmid:8929120
|
Vasil'ev MM and Gazarian IIu |
[Clinico-laboratory evaluation of the effectiveness of azithromycin in the treatment of patients with Chlamydia and mixed Chlamydia-gonorrhea infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929122
|
Bingen E et al. |
Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821495
|
Pettus K et al. |
In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25624328
|
Retsema J et al. |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2449865
|
Wondrack L et al. |
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849266
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Bohte R et al. |
Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593024
|
Beringer P et al. |
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304166
|
Ulrich M et al. |
Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304181
|
Girard AE et al. |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2830841
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Vallée E et al. |
Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324644
|
Merchan LM et al. |
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25385115
|
Mertens JC et al. |
Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324645
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Feola DJ et al. |
Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20231397
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Bonnet M and Van der Auwera P |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329619
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Koletar SL et al. |
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582873
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Marchisio P et al. |
Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124831
|
Jacobsson S et al. |
Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28893785
|
Zarantonelli L et al. |
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10508026
|
Seyama S et al. |
Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28848006
|
Koetsveld J et al. |
Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28674060
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Kemp MW et al. |
Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155606
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Zheng S et al. |
Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155592
|
Descours G et al. |
Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28069647
|
Ng LK et al. |
Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183262
|
Prunier AL et al. |
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183270
|
Engel JN |
Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1280057
|
Saini H et al. |
Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28031194
|
Binet R and Maurelli AT |
Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17908942
|
Collins SA et al. |
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27919896
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Starner TD et al. |
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms. |
2008 |
Antimicrob. Agents Chemother. |
pmid:17954687
|
Brieland JK et al. |
Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10770771
|
Turcinov D et al. |
Failure of azithromycin in treatment of Brill-Zinsser disease. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817744
|
Luke DR et al. |
Safety, toleration, and pharmacokinetics of intravenous azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913468
|
Tsitsika A et al. |
Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817749
|
Scorneaux B et al. |
Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8723471
|
Olsen KM et al. |
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913469
|
Bin XX et al. |
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817751
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Pacifico L et al. |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849215
|
Galarza PG et al. |
New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20123998
|
Mukherjee P et al. |
Emergence of high-level azithromycin resistance in Campylobacter jejuni isolates from pediatric diarrhea patients in Kolkata, India. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24777098
|
Jaruratanasirikul S et al. |
Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851625
|
Achard A et al. |
Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18519724
|
Zasowski E et al. |
Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752270
|
Rouse MS et al. |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257739
|
Wong MH et al. |
Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752251
|
Carryn S et al. |
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12069960
|
Jeong BH et al. |
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480854
|
Marvig RL et al. |
Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22644032
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Erhardt W et al. |
Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media. |
2000 |
Antimicrob. Agents Chemother. |
pmid:11012390
|
Cigana C et al. |
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17210769
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Farrell DJ et al. |
Results from the Solithromycin International Surveillance Program (2014). |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044551
|
Niki Y et al. |
In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840560
|
Freeman CD et al. |
Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840585
|
Chinh NT et al. |
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858343
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Sugimura M et al. |
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18676884
|
Liu P et al. |
Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21859932
|
Shima K et al. |
Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23478971
|
Pfefferkorn ER and Borotz SE |
Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8141576
|
Bermudez LE et al. |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067766
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Goodman CD et al. |
Chemobiosynthesis of new antimalarial macrolides. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23208707
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Kim MK et al. |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12234843
|
Allen GP and Harris KA |
Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28483960
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Araujo FG et al. |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840017
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Caronzolo D et al. |
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561871
|
Carter G et al. |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561879
|
Pereira MR et al. |
In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21464242
|
Roord JJ et al. |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124837
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Gnarpe J et al. |
In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843291
|
Schroeck JL et al. |
Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25870064
|
Dreses-Werringloer U et al. |
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600348
|
Tateda K et al. |
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11353657
|
Gödeke J et al. |
Recycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23318806
|
Ouadrhiri Y et al. |
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223943
|
Könönen E et al. |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223950
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Akova M et al. |
In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223958
|
Edelstein PH et al. |
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11451675
|